Reuters
13 Sept 2026, 11:17 UTC · 7h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
1 claim · each scored for market impact
GE HealthCare Technologies is in talks to acquire radiopharmaceutical developer Sofie Biosciences for approximately $1 billion. — A billion-dollar expansion into high-growth radiopharmaceuticals signals strategic growth and potential revenue diversification for GE HealthCare.
+0.40Which stocks this story touches
Potential $1 billion acquisition to expand capabilities in the radiopharmaceutical market.
Continue reading
5 related stories
Search tags
MarketBeat · 3h ago
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
13h ago
